Langdon SP - Search Results

1

Multi-Scale Genomic, Transcriptomic and Proteomic Analysis of Colorectal Cancer Cell Lines to Identify Novel Biomarkers.

Briffa R, Um I, Faratian D, Zhou Y, Turnbull AK, Langdon SP, Harrison DJ. Briffa R, et al. Among authors: langdon sp. PLoS One. 2015 Dec 17;10(12):e0144708. doi: 10.1371/journal.pone.0144708. eCollection 2015. PLoS One. 2015. PMID: 26678268 Free PMC article.

2

Gonadotropin-releasing hormone receptor levels and cell context affect tumor cell responses to agonist in vitro and in vivo.

Morgan K, Stewart AJ, Miller N, Mullen P, Muir M, Dodds M, Medda F, Harrison D, Langdon S, Millar RP. Morgan K, et al. Cancer Res. 2008 Aug 1;68(15):6331-40. doi: 10.1158/0008-5472.CAN-08-0197. Cancer Res. 2008. PMID: 18676858

3

Systems biology reveals new strategies for personalizing cancer medicine and confirms the role of PTEN in resistance to trastuzumab.

Faratian D, Goltsov A, Lebedeva G, Sorokin A, Moodie S, Mullen P, Kay C, Um IH, Langdon S, Goryanin I, Harrison DJ. Faratian D, et al. Cancer Res. 2009 Aug 15;69(16):6713-20. doi: 10.1158/0008-5472.CAN-09-0777. Epub 2009 Jul 28. Cancer Res. 2009. PMID: 19638581

4

Modulation of HER3 is a marker of dynamic cell signaling in ovarian cancer: implications for pertuzumab sensitivity.

Nagumo Y, Faratian D, Mullen P, Harrison DJ, Hasmann M, Langdon SP. Nagumo Y, et al. Among authors: langdon sp. Mol Cancer Res. 2009 Sep;7(9):1563-71. doi: 10.1158/1541-7786.MCR-09-0101. Epub 2009 Sep 8. Mol Cancer Res. 2009. PMID: 19737968 Free article.

5

How can systems pathology help us personalize cancer therapy?

Faratian D, Langdon SP, Harrison DJ. Faratian D, et al. Among authors: langdon sp. Discov Med. 2009 Aug;8(41):81-6. Discov Med. 2009. PMID: 19788873 Free article.

6

Quantitative analysis of changes in ER, PR and HER2 expression in primary breast cancer and paired nodal metastases.

Aitken SJ, Thomas JS, Langdon SP, Harrison DJ, Faratian D. Aitken SJ, et al. Among authors: langdon sp. Ann Oncol. 2010 Jun;21(6):1254-1261. doi: 10.1093/annonc/mdp427. Epub 2009 Oct 25. Ann Oncol. 2010. PMID: 19858088 Free article.

7

The importance of growth factors and steroid hormones in ovarian cancer.

Langdon SP, Faratian D, Harrison DJ. Langdon SP, et al. Onkologie. 2009 Nov;32(11):623-4. doi: 10.1159/000246764. Epub 2009 Oct 16. Onkologie. 2009. PMID: 19887864 Free article. No abstract available.

8

Reply to: discordant expression of molecular markers between primary and nodal metastases: a histopathological manifestation of the 'self (stem cell)-seeding' nature of breast cancer disease?

Faratian D, Aitken SJ, Thomas JS, Langdon SP, Harrison DJ. Faratian D, et al. Among authors: langdon sp. Ann Oncol. 2010 Jun;21(6):1375. doi: 10.1093/annonc/mdq046. Epub 2010 Mar 9. Ann Oncol. 2010. PMID: 20215137 Free article. No abstract available.

9

Pertuzumab for the treatment of ovarian cancer.

Langdon SP, Faratian D, Nagumo Y, Mullen P, Harrison DJ. Langdon SP, et al. Expert Opin Biol Ther. 2010 Jul;10(7):1113-20. doi: 10.1517/14712598.2010.487062. Expert Opin Biol Ther. 2010. PMID: 20465533 Review.

10

Dynamic changes in gene expression in vivo predict prognosis of tamoxifen-treated patients with breast cancer.

Taylor KJ, Sims AH, Liang L, Faratian D, Muir M, Walker G, Kuske B, Dixon JM, Cameron DA, Harrison DJ, Langdon SP. Taylor KJ, et al. Among authors: langdon sp. Breast Cancer Res. 2010;12(3):R39. doi: 10.1186/bcr2593. Epub 2010 Jun 22. Breast Cancer Res. 2010. PMID: 20569502 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

185 results

Search Page

Filters